Radio and PodcastLive Radio & PodcastsScience & Medicine
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics - New FDA Approvals
Related Episodes
Continue listening to more episodes from New FDA Approvals.